Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade.
about
Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull miceLocalization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive EpitopesDendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue virusesMaturation of dengue virus nonstructural protein 4B in monocytes enhances production of dengue hemorrhagic fever-associated chemokines and cytokinesDengue: defining protective versus pathologic immunityDengue virus selectively induces human mast cell chemokine productionZika virus productively infects primary human placenta-specific macrophagesMacrophage heterogeneity in tissues: phenotypic diversity and functionsUnderstanding the dengue viruses and progress towards their controlStudy of Dengue virus infection in SCID mice engrafted with human K562 cells.Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons.Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primatesRelease of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil lineInfection of human cells by dengue virus is modulated by different cell types and viral strainsChimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell responseInfection of primary cultures of human Kupffer cells by Dengue virus: no viral progeny synthesis, but cytokine production is evident.Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis.Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion.Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infectionsThe four serotypes of dengue recognize the same putative receptors in Aedes aegypti midgut and Ae. albopictus cellsDifferential Enhancement of Dengue Virus Immune Complex Infectivity Mediated by Signaling-Competent and Signaling-Incompetent Human Fc RIA (CD64) or Fc RIIA (CD32)Both Virus and Tumor Necrosis Factor Alpha Are Critical for Endothelium Damage in a Mouse Model of Dengue Virus-Induced HemorrhageIdentification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clonesMultiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virusDemonstration of binding of dengue virus envelope protein to target cellsPre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse modelDengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell deathActivation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytesDengue Virus (DV) Replication in Monocyte-Derived Macrophages Is Not Affected by Tumor Necrosis Factor Alpha (TNF- ), and DV Infection Induces Altered Responsiveness to TNF- StimulationHigh Pro-Inflammatory Cytokine Secretion and Loss of High Avidity Cross-Reactive Cytotoxic T-Cells during the Course of Secondary Dengue Virus InfectionPrimary Human Splenic Macrophages, but Not T or B Cells, Are the Principal Target Cells for Dengue Virus Infection In VitroComplement Protein C1q Inhibits Antibody-Dependent Enhancement of Flavivirus Infection in an IgG Subclass-Specific MannerHigher Infection of Dengue Virus Serotype 2 in Human Monocytes of Patients with G6PD DeficiencyTRAIL Is a Novel Antiviral Protein against Dengue VirusElevated levels of soluble ST2 protein in dengue virus infected patientsClosing the door on flaviviruses: Entry as a target for antiviral drug designHumoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle AntigensImmunization with Heterologous Flaviviruses Protective Against Fatal West Nile EncephalitisProgress on the development of therapeutics against West Nile virus
P2860
Q21142740-758DE4B6-4584-454F-9FF3-9A73E1E22246Q24289053-4AE3F6AC-2ABA-4232-ADDE-CADE6022FBF1Q24536024-2B7E56F5-6B51-4A4D-A0BF-B15070FC7D8BQ24570135-42892278-BBE7-423A-972B-164C7F7C4882Q24609884-CDFABF7C-E22F-47BC-A0BF-0A92DC093DCAQ24673736-CBC4C4CB-ED87-4323-8E19-7757D46C5BF8Q26336601-F22D3F74-1A23-4A4A-A1A4-783DF114C5CAQ26861223-32939F07-4857-4A50-BAAA-E4A22AF6824FQ27011587-4980488B-A64F-43EF-9B4B-B3FE48EB114FQ27469587-5AE3C82C-915E-401A-836F-C917E07AFF19Q27469591-61321895-7814-4F8D-B132-FC2B5049153AQ27469664-37162B98-5D66-453F-BF52-21E7AF4F38AAQ27469685-59D566C6-5C54-4E90-BEC0-DABF031314AFQ27469687-C0DACF63-E62E-4CF5-9247-0C57F7A2B797Q27469691-CE3B06C3-3440-42D1-9554-980F63FEA963Q27469710-6F81425E-6361-4C4D-ADD2-201306D0BB47Q27469896-70EB858E-E777-4239-AC04-607F00C8C189Q27469921-93F06466-F90F-490D-8E5F-52CC9AE420A1Q27470758-D3BF8370-BDC8-4A97-B590-7BDB665BF97FQ27473433-03E8A444-4A5A-4DF3-A835-0A94805BCA26Q27477510-EE96D40E-8070-4842-8FD8-1E795826A152Q27477546-9C5B418E-CD7F-44CE-B6A6-B5966D81C197Q27480369-734BC29C-AA38-4EE9-8A5B-8E53FAAAB726Q27480380-2D296542-0BA7-46DF-B223-2F9A03436535Q27480738-E5B4ADC1-7DF5-438A-A6E7-53B8D0FC4802Q27480760-6BBD510E-6373-4275-A436-F96F450361E1Q27480808-AFA36C98-2FEF-4E3C-83FD-36D4CDD98FABQ27480811-1D4ADE6B-731E-4E32-B086-47BB6C626288Q27480826-024A6DA4-95AF-4FE2-9E41-3EC4D2704BCCQ27481475-776ECE03-9802-4A59-8AAE-BD6E88B0202CQ27481682-88EB40C3-F6A7-49C9-A38C-DDA1EA5C6210Q27485010-DCE0181E-7F4C-4D04-AFAF-EBA3FF1A611CQ27485131-DBED5FF9-C381-4EAB-A7E5-CD93D4327DEEQ27485240-05143666-E5E0-431F-97D7-676AE6413542Q27485295-82AEFCC6-8FBA-4532-9D55-84C2B64B2264Q27485633-5230BD76-8EB3-4899-92DF-2E92B3678265Q27487953-1365BDDC-6A4B-4E5D-B616-585F45D41A6EQ27488243-58742F91-2F20-4E6C-B919-648B4D7CA455Q27489404-8D6D5942-D9FF-4FC0-9CCC-E8D59F0419D1Q27489893-989F922C-6076-4A6A-9A46-05AF2A191B25
P2860
Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Antibody, macrophages, dengue ...... rhage: a pathogenetic cascade.
@en
type
label
Antibody, macrophages, dengue ...... rhage: a pathogenetic cascade.
@en
prefLabel
Antibody, macrophages, dengue ...... rhage: a pathogenetic cascade.
@en
P921
P1476
Antibody, macrophages, dengue ...... rhage: a pathogenetic cascade.
@en
P304
P478
11 Suppl 4
P577
1989-05-01T00:00:00Z